RECOMBINANT AND ADVANCED VACCINES AGAINST THE INFLUENZA VIRUS AND THE HERPES VIRUS.
Номер патента: ES2237931T3
Опубликовано: 01-08-2005
Автор(ы): Jean-Christophe Francis Audonnet, Jules Maarten Minke
Принадлежит: Merial SAS
Опубликовано: 01-08-2005
Автор(ы): Jean-Christophe Francis Audonnet, Jules Maarten Minke
Принадлежит: Merial SAS
Реферат: Vacuna viva recombinante que comprende un vector viral que incorpora y expresa in vivo una secuencia nucleotídica heteróloga seleccionada entre un gen de un herpes virus animal y un gen de un virus influenza, y al menos un compuesto adyuvante seleccionado entre los polímeros del ácido acrílico o metacrílico y los copolímeros de anhídrido maléico y de derivado alquenilo. Recombinant live vaccine comprising a viral vector that incorporates and expresses in vivo a heterologous nucleotide sequence selected from a herpes virus animal gene and an influenza virus gene, and at least one adjuvant compound selected from acrylic or methacrylic acid polymers and the copolymers of maleic anhydride and alkenyl derivative.
Live recombinant vaccines comprising an adjuvant compound and a viral vector comprising a gene of an animal herpes or influenza virus
Номер патента: CA2321903C. Автор: Jean-Christophe Francis Audonnet,Jules Maarten Minke. Владелец: Merial SAS. Дата публикации: 2011-05-31.